INFANTS' TYLENOL ORAL SUSPENSION OTC
Generic Name and Formulations:
Acetaminophen 160mg/5mL; cherry or grape flavor; alcohol-free.
McNeil Consumer Healthcare
Indications for INFANTS' TYLENOL ORAL SUSPENSION:
Minor aches and pain. Fever.
Dispense liquid slowly in mouth toward inner cheek. <24lbs or <2yrs: consult doctor. 24–35lbs or 2–3yrs: 5mL (160mg) every 4hrs; max 5 doses/24hrs.
Hepatic dysfunction. Reevaluate if severe sore throat persists >2 days with or followed by fever, headache, rash, nausea or vomiting. Discontinue if new symptoms occur, pain worsens >5 days, fever persists >3 days, or if redness or swelling is present.
Do not use with other acetaminophen-containing drugs. Caution with concomitant warfarin.
Susp (w. oral syringe)—1oz (grape); 2oz (cherry)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers
- Finding Clinical Trials in Cancer
- Combining Chemotherapy With Checkpoint Inhibitors Extends Overall Survival in ES-SCLC
- In a Head-to-Head Battle, Brigatinib Appears to Best Crizotinib
- Durvalumab Shows Overall Survival Benefit in Patients With Stage III NSCLC
- Baseline Thrombopoietin Levels May Help Predict Response to ITP Treatment
- Despite Promising Trial Results, Skeptics Raise Red Flags About Anlotinib's Efficacy in Heavily Treated NSCLC